Chinese Medical Journal review highlights senescence’s dual role in liver disease and emerging therapies
Peer-Reviewed Publication
Updates every hour. Last Updated: 14-Jul-2025 05:11 ET (14-Jul-2025 09:11 GMT/UTC)
Cellular senescence, where cells permanently stop dividing, plays a complex role in liver health. In a recent review article, researchers from China examined the mechanisms behind senescence, its impact on liver cells, and its contribution to liver diseases like metabolic dysfunction-associated steatohepatitis (MASH), cirrhosis, and hepatocellular carcinoma. The review also highlights the potential of senolytic therapies, which target senescent cells to reduce damage, offering hope for improved liver disease treatments.
Robust microbiome signatures enable more precise diagnoses and open up new therapeutic approaches for the treatment of NAFLD
Houston Methodist researchers identified a key protein as a potential therapeutic target for stopping the body’s immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and allergies. The researchers proved if they therapeutically target the protein Apex1 with chemical inhibitors to either turn it off or remove it completely, then this could be a highly effective way to block immune-mediated diseases. The study appeared recently in the Journal of Clinical Investigation.